The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection

被引:46
作者
Heintel, T
Sester, M
Rodríguez, MMB
Krieg, C
Sester, U
Wagner, R
Pees, HW
Gärtner, B
Maier, R
Meyerhans, A [1 ]
机构
[1] Univ Saarland, Inst Med Microbiol & Hyg, Dept Virol, D-66421 Homburg, Germany
[2] Univ Saarland, Dept Med 4, D-66421 Homburg, Germany
[3] Univ Saarland, Dept Med 1, D-66421 Homburg, Germany
[4] Univ Regensburg, Inst Med Microbiol & Hyg, Dept Virol, D-8400 Regensburg, Germany
关键词
HIV; cytomegalovirus; intracellular cytokine staining; perforin; virus-specific T cells;
D O I
10.1097/00002030-200207260-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Perforin is an important component of the death machinery of cytotoxic T cells (CTL). To evaluate functional differences between HIV- and cytomegalovirus (CMV)-specific CTL of coinfected patients, the frequencies of the respective perforin-expressing T cells were analysed in a rapid whole blood assay. Methods: Whole blood of HIV- and CMV-infected individuals was specifically stimulated by HIV-1 Pr55(gag) or complete CMV antigen, and activation-induced intracellular cytokine and perforin expression in CD8 T cells was analysed by flow cytometry. Results: Perforin-expressing HIV-1- and CMV-specific CD8 T cells can be quantified simultaneously. Within a patient, the frequency of such HIV-specific CD8 T cells in peripheral blood was lower than the frequency of the respective CMV-specific cells. The number of the perforin-expressing HIV-specific CD8 T cells inversely correlated with the peripheral blood CD4 T cell count. Conclusions: The differential fractions of perforin-expressing virus-specific CD8 T cells in HIV and CMV double infection might be caused by differences in priming and trafficking to or from replication sites. However, without knowing the underlying mechanism, the fraction of perforin-expressing HIV-specific CD8 T cells provides another surrogate marker for disease progression. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:1497 / 1501
页数:5
相关论文
共 27 条
[1]   HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function [J].
Appay, V ;
Nixon, DF ;
Donahoe, SM ;
Gillespie, GMA ;
Dong, T ;
King, A ;
Ogg, GS ;
Spiegel, HML ;
Conlon, C ;
Spina, CA ;
Havlir, DV ;
Richman, DD ;
Waters, A ;
Easterbrook, P ;
McMichael, AJ ;
Rowland-Jones, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :63-75
[2]  
Caruso A, 2000, J ACQ IMMUN DEF SYND, V24, P465, DOI 10.1097/00126334-200008150-00012
[3]   Skewed maturation of memory HIV-specific CD8 T lymphocytes [J].
Champagne, P ;
Ogg, GS ;
King, AS ;
Knabenhans, C ;
Ellefsen, K ;
Nobile, M ;
Appay, V ;
Rizzardi, GP ;
Fleury, S ;
Lipp, M ;
Förster, R ;
Rowland-Jones, S ;
Sékaly, RP ;
McMichael, AJ ;
Pantaleo, G .
NATURE, 2001, 410 (6824) :106-111
[4]   Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8+ T lymphocytes in healthy seropositive donors [J].
Gillespie, GMA ;
Wills, MR ;
Appay, V ;
O'Callaghan, C ;
Murphy, M ;
Smith, N ;
Sissons, P ;
Rowland-Jones, S ;
Bell, JI ;
Moss, PAH .
JOURNAL OF VIROLOGY, 2000, 74 (17) :8140-8150
[5]  
GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904
[6]   Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation [J].
Graubert, TA ;
DiPersio, JF ;
Russell, JH ;
Ley, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (04) :904-911
[7]  
GREEN WR, 1978, J IMMUNOL, V121, P1566
[8]   Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: Evidence supporting a protective role for CTL in vivo [J].
Greenough, TC ;
Brettler, DB ;
Somasundaran, M ;
Panicali, DL ;
Sullivan, JL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :118-125
[9]   EXPRESSION OF PERFORIN AND GRANZYMES INVIVO - POTENTIAL DIAGNOSTIC MARKERS FOR ACTIVATED CYTOTOXIC-CELLS [J].
GRIFFITHS, GM ;
MUELLER, C .
IMMUNOLOGY TODAY, 1991, 12 (11) :415-419
[10]   Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection [J].
Harrer, T ;
Harrer, E ;
Kalams, SA ;
Elbeik, T ;
Staprans, SI ;
Feinberg, MB ;
Cao, YZ ;
Ho, DD ;
Yilma, T ;
Caliendo, AM ;
Johnson, RP ;
Buchbinder, SP ;
Walker, BD .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (07) :585-592